EUVIMEDOtkrijte EUVIMED
CrossrefInformacijska kartica

Two‐stage anterotransposition of the brachial vein as the new option for native vascular access for hemodialysis: A report of 3 cases

Stanislaw Przywara, Jacek Wronski, Piotr Terlecki, Tomasz Zubilewicz, Marcin Feldo, Anna Skublewska‐Bednarek

Dialysis & Transplantation · 2006

DOI: 10.1002/dat.20009 ↗
SažetakBibliografski podaci

Sažetak

Abstract Background We present 3 cases of 2‐stage anterotransposition of the brachial vein to be considered the last option for native vascular access for hemodialysis before forearm/upper arm graft placement. Methods Three patients with chronic renal insufficiency were admitted for the creation of vascular access for hemodialysis. Physical examination, confirmed by ultrasonography, revealed the absence of adequate cephalic and basilic veins. In each case, precise color Doppler ultrasound examination showed a brachial artery with the appropriate diameter and 2 wide brachial veins joining into 1 axillary vein in the axillary fossa. Surgery was performed in 2 stages. In the first stage, one of the brachial veins was anastomosed with the brachial artery end to side in the cubital fossa. The fistula was left for 4 weeks to mature, with the brachial vein in its anatomical location. During the second stage, the entire length of the brachial vein was exposed via 1 longitudinal incision from cubital fossa up to armpit. Mobilized vein was subcutaneously transposed to an anterior location. Results At present, 8–20 months after the procedure, venous pressures are within accepted ranges and hemodialysis is adequate. Conclusions Our technical report confirms that the brachial vein can be utilized as the last option for the creation of native vascular access on the upper arm. We recommend that the surgery be performed in 2 stages. Maturation of the vein in its anatomical location, which occurs between the first and second stages of surgery, assures proper dilatation and thickening of the vein, making it better able to resist the extensive dissection and transposition during the second stage.

Znanje koje odgovara vašem radu.

Od besplatnog početka i osobnog pretraživanja literature do potpunog paketa Research Suite.

Prikaži tarife →

Jesu li uključeni svi cjeloviti tekstovi izdavača?

Ne. Bibliografski zapisi, sažeci i cjeloviti tekstovi različiti su sadržaji. Hoće li cjeloviti tekst biti dostupan ovisi o izvoru, Open Accessu i vašim postojećim licencama. Tarifa EUVIMED ne zamjenjuje dodatna izdavačka prava.

Prikaži tarife →